MedTrace Logo

GI Medical Cannabis Study on IBD

NCT03886532 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-09-27

No results posted yet for this study

Summary

Create a registry that will described the natural history and landscape of medical cannabis product use in patients with chronic abdominal pain or inflammatory bowel disease.

Quantitatively describe the pharmacokinetic (PK) profile of select medical cannabis products in patients with chronic neuropathic (abdominal) pain or inflammatory bowel disease.

To create an educational program for families that have participated in the research for those families who opt for this component. Although these are not research in nature, they are a direct result of the proposed research and are included in the protocol to demonstrate the study's deliverables.

Conditions

  • Inflammatory Bowel Diseases
  • Neuropathic Pain

Interventions

OTHER

Medical Marijuana

registry and blood samples

Sponsors & Collaborators

Principal Investigators

  • Athena F Zuppa, MD MSCE · Children's Hospital of Philadelphia

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03886532 on ClinicalTrials.gov